NOT A HOLE.
AN EMERGING CATEGORY.
Micro Invasive Glaucoma Surgery (MIGS) is emerging to transform glaucoma therapy by offering new and compelling treatment options for the
glaucoma patient. MIGS is also attracting attention both within and beyond ophthalmology. The Wall Street Journal (WSJ) recently selected and
ranked Glaukos Corporation, the corporate leader of MIGS, number 7 out of a pool of 5,900 venture-capital—backed companies.
1
Moreover, the WSJ
selected Glaukos as the nation's top healthcare start-up company. MIGS is beginning to change perspectives and the care of the glaucoma patient.
To learn more contact Glaukos at 800.452.8567 or visit www.glaukos.com.
REFERENCE: 1. Basich Z, Maltby E. Less Flash Draws More Cash: Ranking of Top
50 Start-Ups Reveals Focus on Business Technology as Health Care, Energy Fade.
The Wall Street Journal. September 27, 2012:B1.
©
2013 Glaukos Corporation. Glaukos is a registered trademark of Glaukos Corporation.
Visit us at booth #2408.
